CCRM

CCRM operates from its Toronto headquarters as Canada's primary commercialization hub for cell and gene therapy development, specializing in the translation of laboratory discoveries into clinical applications. The organization maintains dedicated facilities for bioprocessing development and scalable manufacturing platform creation, supporting the progression of regenerative medicine products through preclinical testing. Through its Good Manufacturing Practice (GMP) facility, CCRM provides specialized biomanufacturing services to both academic and industry partners. The organization advances regenerative medicine through three core activities: strategic partnership development, funding program administration, and intellectual property portfolio management. CCRM established the Logan Award program to recognize excellence in scientific communication within the field. The organization works directly with regulatory bodies to establish compliance frameworks for emerging cell therapy technologies. CCRM's network encompasses academic research institutions, biotechnology firms, and clinical development partners across Canada's regenerative medicine ecosystem. The organization provides standardization protocols for cell therapy production processes and quality control systems. CCRM's technology transfer initiatives help position Canadian innovations within the global regenerative medicine market.